Prostatic cancer
Conditions
Interventions
Group of prostate cancer patients treated with revilutamide:None
Sponsors
QingHai University Affiliated Hospital
Eligibility
Sex/Gender
Male
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Age >= 18 years old; 2.Pathologically confirmed prostate cancer patients; 3.Sign an informed consent form and voluntarily participate in this study; 4.The researchers determine that treatment with revalutamide can be used, or that they have received or are currently receiving revalutamide treatment;
Exclusion criteria
Exclusion criteria: 1.The patient is currently participating in other clinical intervention studies; 2.Unable to understand the nature of the research or did not obtain informed consent; 3.The researcher determines other situations that are not suitable for inclusion in the study;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| safe; | — |
Secondary
| Measure | Time frame |
|---|---|
| DOT,Duration of treatment;rPFS,Progression-free survival in imaging studies;DOR,Duration of relief;ORR,Objective relief rate;Start of the first follow-up treatment time for advanced prostate cancer;Overall survival; | — |
Countries
China
Contacts
Public ContactChen Guojun
QingHai University Affiliated Hospital
Outcome results
None listed